Osthol (osthole), known as a neuroprotective drug, has shown potent anticancer activity. However, the potential clinical application of osthol is limited due to its low water solubility and low bioavailability. Polybutyl cyanoacrylate (PBCA) has been widely used to improve the solubility of drugs with poor water solubility. In this study, an orthogonal experimental design (OED) was applied to design the preparation process of PBCA nanoparticles (NPs). Then, nanoparticles were prepared and evaluated in terms of physicochemical properties, in vitro release, and cellular uptake, etc. Further, the anti-cancer activity of osthol-PBCA NPs was demonstrated in SH-SY5Y cells. The pharmacokinetics and area under the curve (AUC) were investigated. The obtained osthol-NPs presented a spherical shape with a particle size of 110 ± 6.7 nm, a polydispersity index (PDI) of 0.126, and a zeta potential of −13 ± 0.32 mV. Compared with the free osthol, the drugs in osthol-NPs presented better stability and sustained release pattern activity. In vitro analysis using SH-SY5Y neuroblastoma cells showed that osthol-loaded nanoparticles displayed a significantly enhanced intracellular absorption process (three times) and cytotoxicity compared with free osthol (p < 0.05, increased 10–20%). The in vivo pharmacokinetic study revealed that the AUC of osthol-NPs was 3.3-fold higher than that of free osthol. In conclusion, osthol-PBCA NPs can enhance the bioactivity of osthol, being proposed as a novel, promising vehicle for drug delivery.
To investigate the susceptibility of SH-SY5Ycells to DTPP-based photodynamic therapy(PDT) and the interaction with chrysophanol. Cells were treated with increasing concentrations of DTPP between 2.5 to 20 μg·mL-1 and the DTPP -induced killing effects in tumor cells was quantified determined. PDT photocytotoxicity was measured by exposing the cells to a 630-nm irradiation for 1.2–9.6 J/cm2. The photodynamicstress was assessed by superoxide dismutase, malondialdehyde, and total antioxidative capacity assays. The apoptosis pathway of SH-SY5Y cells after PDT was studied by JC-1 and caspase-9/Caspase-3 determination. The cell apoptosis cells stained with Annexin-V-FITC and propidium iodide were detected through flow cytometry. In the PDT process, a dose-dependent killing effect of DTPP concentrations and irradiation doses were found. The viability of SH-SY5Y cells treated with 10 μg·mL-1 DTPP rapidly decreased to 55%. Cells apoptosis is mediated by a mitochondrial -pathway with a total apoptosis rate of 33.8% with 10 μg·mL-1 of DTPP after illumination at 2.4 J/cm2. Thus, our results demonstrated that an oxidation stress was produced by ROS in PDT and a non-reversible cells oxidative damage appeared via cells modulating the oxidative stress balance during the PDT response. Chr had an inhibitor effect on the capture of ROS and the destruction of cell membrane induced by PDT. In conclusion, neuroblastoma cell line SH-SY5Y cells were susceptible to DTPP-PDT, resulting in a mitochondrial apoptosis pathway. DTPP is a potential type I photosensitizers to revitalize photodynamic oncotherapy in SH-SY5Y cells. There is an antagonism effect of chrysophanol on PDT in SH-SY5Y neuroblastoma cells.